{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:07:46Z","timestamp":1760954866038,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1016\/j.annepidem.2006.04.002","type":"journal-article","created":{"date-parts":[[2006,6,29]],"date-time":"2006-06-29T13:54:09Z","timestamp":1151589249000},"page":"580-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Regarding \u201cPhenylpropanolamine and Hemorrhagic Stroke in the Hemorrhagic Stroke Project\u201d"],"prefix":"10.1016","volume":"16","author":[{"given":"Richard","family":"Clapp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2006.04.002_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.annepidem.2005.01.012","article-title":"Phenylpropanolamine and hemorrhagic stroke in the hemorrhagic stroke project: A reappraisal in the context of science, the Food and Drug Administration, and the law","volume":"16","author":"Stier","year":"2006","journal-title":"Ann Epidemiol"},{"issue":"Suppl","key":"10.1016\/j.annepidem.2006.04.002_bib2","first-page":"S434","article-title":"Phenylpropanolamine in cold remedies and risk of hemorrhagic stroke: Acute brain bleeding analysis study","volume":"36","author":"Yoon","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.annepidem.2006.04.002_bib3","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke","volume":"343","author":"Kernan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annepidem.2006.04.002_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/01.WNL.0000042092.20411.5B","article-title":"Use of ephedra-containing products and risk for hemorrhagic stroke","volume":"60","author":"Morgenstern","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.annepidem.2006.04.002_bib5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1161\/01.STR.0000074572.91827.F4","article-title":"Major risk factors for aneurysmal subarachnoid hemorrhage in the young are modifiable","volume":"34","author":"Broderick","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.annepidem.2006.04.002_bib6","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/01.STR.0000177480.62341.6b","article-title":"Major risk factors for intracerebral hemorrhage in the young are modifiable","volume":"36","author":"Feldmann","year":"2005","journal-title":"Stroke"},{"year":"1987","series-title":"Epidemiology in Medicine","author":"Hennekens","key":"10.1016\/j.annepidem.2006.04.002_bib7"},{"year":"1998","series-title":"Modern Epidemiology, 2nd ed","author":"Rothman","key":"10.1016\/j.annepidem.2006.04.002_bib8"}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279706000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279706000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T02:02:22Z","timestamp":1760925742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279706000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S1047279706000925"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2006.04.002","relation":{},"ISSN":["1047-2797"],"issn-type":[{"type":"print","value":"1047-2797"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regarding \u201cPhenylpropanolamine and Hemorrhagic Stroke in the Hemorrhagic Stroke Project\u201d","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2006.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}